z-logo
open-access-imgOpen Access
Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
Author(s) -
Bishal Gyawali,
Spencer Phillips Hey,
Aaron S. Kesselheim
Publication year - 2020
Publication title -
eclinicalmedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.915
H-Index - 20
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2020.100332
Subject(s) - surrogate endpoint , medicine , breast cancer , clinical endpoint , cancer , oncology , surrogate data , clinical trial , quantum mechanics , nonlinear system , physics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom